Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
  • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
  • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
  • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
  • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
  • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D307/32—Oxygen atoms
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/12—Antihypertensives
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
  • C07C271/06—Esters of carbamic acids
  • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
  • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
  • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
  • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
  • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
  • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D207/24—Oxygen or sulfur atoms
  • C07D207/26—2-Pyrrolidones
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
  • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
  • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
  • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D307/32—Oxygen atoms
  • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
  • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
  • Y02P20/00—Technologies relating to chemical industry
  • Y02P20/50—Improvements relating to the production of bulk chemicals
  • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Cardiology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Pharmacology & Pharmacy (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Engineering & Computer Science (AREA)
• Public Health (AREA)
• Heart & Thoracic Surgery (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Plural Heterocyclic Compounds (AREA)
• Pyrrole Compounds (AREA)
• Furan Compounds (AREA)
• Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
• Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Indole Compounds (AREA)
• Hydrogenated Pyridines (AREA)
• Peptides Or Proteins (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=35451886

Family Applications (1)

Country Status (29)

Families Citing this family (20)

Family Cites Families (16)

• 2005
  • 2005-10-17 GB GBGB0521083.6A patent/GB0521083D0/en not_active Ceased
• 2006
  • 2006-10-13 AR ARP060104497A patent/AR058089A1/es not_active Application Discontinuation
  • 2006-10-15 JO JO2006369A patent/JO2926B1/en active
  • 2006-10-16 HR HRP20130793TT patent/HRP20130793T1/hr unknown
  • 2006-10-16 PL PL06828821T patent/PL1948643T3/pl unknown
  • 2006-10-16 PE PE2006001252A patent/PE20070792A1/es active IP Right Grant
  • 2006-10-16 DK DK06828821.6T patent/DK1948643T3/da active
  • 2006-10-16 CN CN2006800035979A patent/CN101111493B/zh not_active Expired - Fee Related
  • 2006-10-16 BR BRPI0617492-2A patent/BRPI0617492A2/pt not_active Application Discontinuation
  • 2006-10-16 RU RU2008119276/04A patent/RU2432354C2/ru not_active IP Right Cessation
  • 2006-10-16 CN CN201210566662.6A patent/CN103121995B/zh not_active Expired - Fee Related
  • 2006-10-16 CA CA2625034A patent/CA2625034C/en not_active Expired - Fee Related
  • 2006-10-16 CA CA2829487A patent/CA2829487A1/en not_active Abandoned
  • 2006-10-16 NZ NZ567042A patent/NZ567042A/en not_active IP Right Cessation
  • 2006-10-16 ES ES06828821T patent/ES2427098T3/es active Active
  • 2006-10-16 SI SI200631641T patent/SI1948643T1/sl unknown
  • 2006-10-16 JP JP2008535948A patent/JP5356031B2/ja not_active Expired - Fee Related
  • 2006-10-16 AU AU2006303489A patent/AU2006303489B2/en not_active Ceased
  • 2006-10-16 TW TW095138055A patent/TWI395733B/zh not_active IP Right Cessation
  • 2006-10-16 KR KR1020087009098A patent/KR101294432B1/ko not_active Expired - Fee Related
  • 2006-10-16 PT PT68288216T patent/PT1948643E/pt unknown
  • 2006-10-16 PE PE2011001455A patent/PE20120581A1/es active IP Right Grant
  • 2006-10-16 EP EP06828821.6A patent/EP1948643B1/en active Active
  • 2006-10-16 US US12/088,457 patent/US7772405B2/en active Active
  • 2006-10-16 WO PCT/EP2006/009970 patent/WO2007045420A2/en not_active Ceased
• 2008
  • 2008-03-20 IL IL190330A patent/IL190330A/en active IP Right Grant
  • 2008-03-25 ZA ZA200802632A patent/ZA200802632B/xx unknown
  • 2008-04-15 MY MYPI20081108A patent/MY145466A/en unknown
  • 2008-04-15 EC EC2008008368A patent/ECSP088368A/es unknown
  • 2008-04-16 TN TNP2008000170A patent/TNSN08170A1/en unknown
  • 2008-05-16 NO NO20082263A patent/NO342854B1/no not_active IP Right Cessation
• 2010
  • 2010-06-25 US US12/823,699 patent/US8198465B2/en active Active
• 2012
  • 2012-09-26 JP JP2012213001A patent/JP5792139B2/ja not_active Expired - Fee Related
• 2013
  • 2013-09-02 CY CY20131100754T patent/CY1114308T1/el unknown
• 2014
  • 2014-05-21 JP JP2014105430A patent/JP2014196312A/ja not_active Withdrawn

Also Published As

Similar Documents